CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate.

Authors :: Bocchia M
Ippoliti M
Gozzetti A
Abruzzese E
Calabrese S
Amabile M
Pirrotta MT
Crupi R
Tozzuoli D
Trawinska MM
Defina M
Martinelli G
Lauria F
Source :: Leukemia [Leukemia] 2008 Feb; Vol. 22 (2), pp. 426-8. Date of Electronic Publication: 2007 Aug 09.
Publication Year :: 2008

Subjects :: Adult
Aged
Benzamides
Bone Marrow pathology
Cell Count
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Male
Middle Aged
Remission Induction
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Piperazines therapeutic use
Pyrimidines therapeutic use

Full Text Access

Tools